News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

True North Therapeutics Appoints James Gilbert, M.D., As Chief Medical Officer


6/17/2014 1:15:52 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

True North Therapeutics, a biotechnology company developing novel therapies that selectively inhibit the Complement system to treat rare diseases, today announced the appointment of James Gilbert, M.D., as the Company’s first Chief Medical Officer (CMO). As CMO, Dr. Gilbert will oversee all clinical development and regulatory activities for the company, as True North advances its lead product candidate, TNT009, into human clinical trials for autoantibody-driven rare diseases that are mediated by the Complement system.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES